جست‌وجوی استاد و پژوهشگر

Hutan Ashrafianمشاهده پروفایل

استاد

• Artificial Intelligence in Medicine
• Metabolic Surgery
• Health Policy
• +۴ مورد دیگر

Professor Hutan Ashrafian is a clinician-scientist and surgeon at the University of Leeds Business School, holding dual roles as Professor of Research Impact and Senior Research Fellow at Imperial College London. His expertise spans AI in healthcare, metabolic surgery, and ancient history. He pioneered STARD-AI and QUADAS-AI guidelines for AI diagnostics, collaborated on AI-driven breast cancer screening with Google and NHS, and led global health policy initiatives. Ashrafian’s work bridges medicine, history, and philosophy, including his contributions to understanding historical figures’ medical conditions, such as King Tutankhamun’s epilepsy. He has authored over 550 publications, 12 books, and holds a PhD in computational physiology and an MBA with distinction. Awards include the Hunterian Prize and Wellcome Trust Fellowship. His research also explores AI ethics, quantum physics paradoxes, and art-based medical diagnostics. Education: PhD in Computational Physiology (Imperial College London) MBA (Warwick Business School) MD (University College London) Bachelor of Science in Immunology (University College London) Research Interests: Ashrafian’s work spans: AI in Medicine: Diagnostic algorithms, guideline development (STARD-AI/QUADAS-AI), and ethical frameworks. Metabolic Surgery: Bariatric interventions, gut microbiome, and obesity treatments. Ancient History: Medical analyses of historical figures (e.g., Tutankhamun, Julius Caesar) and art-based pathology identification. Philosophy: AI rights (AIONAI law), temporal paradoxes, and the Simulation Argument. Awards: Royal College of Surgeons Arris and Gale Lectureship Hunterian Prize Wellcome Trust Research Fellowship Advising & Innovation: Supervised >50 PhD students, co-founded Oxford Medical Products (weight loss tech), and serves as CSO at Flagship Pioneering’s Preemptive Health division. He advises on NHS digital transformation and global health policy. Labs/Teams: Leads AI initiatives at Imperial’s Institute of Global Health Innovation and collaborates with Google, NICE, and international institutions on health tech solutions.

• Additive Manufacturing
• Aerospace Engineering
• Thermofluids
• +۱ مورد دیگر

Associate Professor Ng Bing Feng leads research in Additive Manufacturing, Aerospace Engineering, and Thermofluids at Nanyang Technological University's School of Mechanical & Aerospace Engineering. As Cluster Director for Smart & Sustainable Building Technologies at NTU's Energy Research Institute, he oversees projects spanning energy-efficient cooling technologies, advanced filtration systems, and bio-inspired materials. His interdisciplinary work integrates advanced manufacturing with environmental engineering, focusing on sustainable solutions for air quality management and thermal regulation. Current research explores radiative cooling technologies, acoustic agglomeration for emissions control, and crashworthy structures via biomimetic design. Professor Ng's publications demonstrate consistent innovation in multi-scale manufacturing and fluid dynamics, with growing emphasis on sustainable urban technologies. Methodologies combine experimental fluid dynamics with computational modeling and AI-driven design. Leadership Roles: Cluster Director, Energy Research Institute @ NTU Principal Investigator for multiple industry collaborations in sustainable materials Research Output: 42+ publications in high-impact journals Multiple patents in filtration technologies and cooling systems

Kora DeBeckمشاهده پروفایل

استاد

• Substance Use
• Drug Policy
• Health Policy
• +۳ مورد دیگر

Kora DeBeck is a Distinguished Professor of Substance Use and Drug Policy in the School of Public Policy at Simon Fraser University, a CIHR Applied Public Health Chair, and Dorothy Killam Fellow. She is also a Research Scientist with the BC Centre on Substance Use and Principal Investigator of the At-Risk Youth Study (ARYS), a longitudinal cohort tracking over 1,200 street-involved youth. Her research focuses on substance use policy, health services for marginalized populations, and the structural drivers of drug-related harms. She has published over 200 peer-reviewed articles challenging ineffective drug enforcement models and advocating for policy reforms. Recent publications analyze trends in opioid use, harm reduction during the COVID-19 pandemic, drug decriminalization, and youth-focused interventions. Her work consistently addresses social inequities through data-driven approaches to the toxic drug crisis. CIHR Applied Public Health Chair Dorothy Killam Fellow Michael Smith Health Research BC Scholar Award Distinguished SFU Professorship She has secured over $50 million in research funding, including $21M as principal investigator for ARYS. Her lab collaborates with healthcare providers, community organizations, and policymakers to translate research into practice.

• Optics in Medicine
• Cancer Imaging
• Photodynamic Therapy
• +۵ مورد دیگر

Brian W. Pogue, Ph.D., is the Robert A. Pritzker Chair in Biomedical Engineering at Dartmouth College's Thayer School of Engineering, with a joint appointment as an Honorary Fellow in Medical Physics at the University of Wisconsin-Madison. His academic background includes a Ph.D. in Medical/Nuclear Physics from McMaster University and a Research Fellowship at Harvard Medical School's Wellman Center for Photomedicine. He has led significant administrative roles, including Dean of Graduate Studies at Dartmouth (2008–2012) and Chair of Medical Physics at Wisconsin (2022–2025). Research Focus : Dr. Pogue pioneers Optics in Medicine , specializing in cancer imaging, photodynamic therapy, and surgical guidance. His work integrates fluorescence imaging, radiation therapy monitoring, and molecular diagnostics to improve cancer treatment precision. Key innovations include Cherenkov imaging for radiotherapy dosimetry and hypoxia-sensitive probes for tumor resection. Publication Trends : Recent articles (2023–2025) emphasize real-time surgical guidance, hypoxia quantification, and multimodal imaging systems. Dominant themes include fluorescence tomography, radiation dosimetry, and low-cost diagnostic devices, reflecting a translational focus from preclinical validation to clinical applications. Awards & Honors : Fellow, Optica (formerly OSA) Fellow, American Institute for Medical and Biological Engineering (AIMBE) Fellow, American Association of Physicists in Medicine (AAPM) Fellow, SPIE (International Society for Optics and Photonics) Funding & Innovation : Continuously funded by the NIH since 2001 ($52M+ total), Dr. Pogue founded three startups: DoseOptics LLC (radiotherapy dose imaging) and Hypoxia Surgical LLC (tissue hypoxia cameras), bridging academic research to clinical tools.

• Health Law
• Privacy Law
• Drug Policy
• +۷ مورد دیگر

Jennifer D. Oliva is a Professor of Law at Indiana University Maurer School of Law where she holds the Val Nolan Faculty Fellow position. She maintains significant interdisciplinary affiliations as a Research Scholar at Georgetown University Law Center's O'Neill Institute for National & Global Health Law and as a Senior Scholar with the UCSF/UC Law Consortium on Law, Science & Health Policy. Her academic work bridges legal scholarship with practical health policy development, focusing on the intersection of constitutional protections, public health needs, and modern surveillance technologies. Professor Oliva's research interests center on health law, privacy law, and drug policy with particular expertise in prescription drug monitoring programs (PDMPs), health information privacy, and the legal dimensions of the opioid crisis. Her scholarship critically examines how law enforcement surveillance of prescription data impacts patient privacy rights, particularly for vulnerable populations including those with substance use disorders. She has developed significant expertise in how constitutional privacy protections apply to health data in the digital age, especially following the Supreme Court's decision in Carpenter v. United States. Her recent publications reveal a growing focus on algorithmic regulation in healthcare, examining how risk scoring systems and coverage algorithms can perpetuate health disparities. She has published extensively on the intersection of reproductive rights and health data privacy in the post-Dobbs landscape, analyzing how prescription monitoring systems could be weaponized against individuals seeking reproductive healthcare. Her work consistently connects doctrinal legal analysis with public health realities, advocating for evidence-based policy approaches that prioritize patient privacy and health equity over punitive enforcement. Dosing Discrimination: Regulating PDMP Risk Scores (2022) The "New" Drug War (2024) Prescription Drug Policing: The Right to Health Information Privacy Pre- and Post-Carpenter (2020) Opioid Multidistrict Litigation Secrecy (2019) Surveillance, Privacy, and App Tracking (2020) Professor Oliva actively engages with policymakers and has contributed to amicus briefs in significant cases including Ruan v. United States. Her scholarship has been cited in legal proceedings and she regularly presents at major academic conferences including the Association of American Law Schools Annual Meeting. She has collaborated with scholars across disciplines including public health researchers, medical ethicists, and data scientists to address complex challenges at the intersection of law, technology, and healthcare.

Basak Tasمشاهده پروفایل

پژوهشگر ارشد

• Opioid overdose and its underlying mechanisms
• Opioid use disorder and related treatment
• Health interventions tackling drug-related morbidity and mortality
• +۲ مورد دیگر

Dr. Basak Tas is a Research Fellow at King's College London, based in the Institute of Psychiatry, Psychology & Neuroscience within the Department of Addictions Sciences. She has been working at King's since 2014, initially as a PhD student and then as a Post-doctoral Research Associate, before taking up her current role in 2021. Her work focuses on opioid overdose and related interventions, collaborating with Professor Sir John Strang and Dr. Will Lawn. Her educational background includes an undergraduate degree in Neuroscience from King's College London and an MSc in Neuroscience from the University of Edinburgh. She completed her PhD at King's College London under the supervision of Professor Sir John Strang, Dr. Caroline Jolley, and Dr. James Bell. Her PhD thesis was titled "Clinical and Laboratory Investigation into Heroin and Opioid Overdose Risk". Dr. Tas's research centers on opioid overdose mechanisms, opioid use disorder treatments, and health interventions to reduce drug-related deaths. She investigates experimental drug studies and develops wearable technologies for overdose detection. Her work aims to understand the physiological underpinnings of overdose and create practical tools for real-world overdose prevention, particularly in high-risk populations. Her recent publications (2020-2025) focus on innovative approaches to prevent opioid overdose deaths, including wearable biosensors (e.g., PneumoWave) and mHealth technologies. She explores risk factors for respiratory depression and the acceptability of detection devices among people who use opioids. Her work bridges laboratory models of overdose with clinical applications in supervised injecting facilities and community settings. Dr. Tas was awarded the following scientific award: Addictions Clinical Academic Group (CAG) Early Career Research Prize (2022) She contributes to teaching by supervising MSc Addiction Studies projects and teaching in the BSc Psychology "Addictions" and "Choices" modules. Additionally, she has been involved in public engagement, including school workshops and the art-science project "Heroin Bodies". Dr. Tas is part of the Drugs Research Group within the Addictions Department at King's, led by Professors John Strang and John Marsden. Her current work involves collaboration on projects related to opioid overdose and wearable technologies.

• Hospital Ventilation
• Indoor Airflow Distribution
• Thermal Comfort
• +۳ مورد دیگر

Guangyu Cao is a Professor at the Department of Energy and Process Engineering, Norwegian University of Science and Technology (NTNU). He holds leadership roles in multiple international organizations, including the European standards working group CEN TC156 WG18, REHVA's technical committee, and the editorial board of the Journal of Building Engineering (Impact Factor 5.318). His research focuses on indoor airflow dynamics, ventilation systems in healthcare settings, and airborne disease transmission mitigation, with a strong emphasis on surgical environments and school buildings. Education: PhD in Energy Engineering (2009), Helsinki University of Technology Senior Researcher at VTT Technical Research Center (2009-2014) Research Interests: Hospital ventilation optimization, thermal comfort in clinical settings, airborne infection control, and sustainable building environmental quality. He combines experimental studies with mathematical modeling to evaluate ventilation strategies, particularly in operating rooms and isolation wards. Projects: EU Marie Curie DTN HumanIC (2024–2027) EU H2020 iclimabuilt (2021–2025) NFR POSIred (2020-2024) Labs/Teams: Collaborates with St. Olav's Hospital on indoor environment projects and leads teams in Cold Climate HVAC and Healthy Building Europe initiatives.

• Radiation Oncology
• Medical Physics
• Cancer Treatment
• +۳ مورد دیگر

Dr Emily Hewson is a Cancer Institute NSW Early Career Fellow and member of the Sydney School of Health Sciences at the University of Sydney's Faculty of Medicine and Health. Her research focuses on advancing real-time radiation therapy techniques, particularly in managing intrafraction motion for prostate and other cancers. She leads projects involving multileaf collimator (MLC) tracking, dose optimization, and deep learning integration in radiation oncology. Research interests include adaptive radiotherapy systems, kilovoltage intrafraction monitoring (KIM), and clinical trial implementation (e.g., TROG 15.01 SPARK trial). Her work emphasizes improving treatment accuracy through real-time dose-guided approaches and multitarget tracking for tumors with complex motion patterns. Developed experimental validations for MRI-linac integration and MLC tracking systems Authored a textbook chapter on Adaptive Radiation Therapy (ART) Recipient of Cancer Institute NSW Early Career Fellowship (2023) Recent grants include an AI platform for targeted radiotherapy (2024) and national critical infrastructure funding for lung cancer applications (2023). Her lab collaborates on real-time dose calculation algorithms and clinical trial implementation across multiple institutions.

Mehmet Karahanمشاهده پروفایل

دانشیار

• Cardiovascular Surgery
• Cardiac Surgery
• Mechanical Circulatory Support
• +۴ مورد دیگر

Mehmet Karahan is an Associate Professor in the Department of Cardiovascular Surgery at Gaziantep University Faculty of Medicine. He specializes in cardiovascular surgery with a focus on mechanical circulatory support, left ventricular assist devices (LVAD), heart transplantation, and endovascular procedures. His clinical and research work centers on innovative approaches to treating complex cardiac conditions. His educational background includes: Medical License (English Program): Hacettepe University Faculty of Medicine (2004-2011), Turkey Specialization in Cardiovascular Surgery: Health Sciences University, Ankara High Specialized Health Application and Research Center (2012-2017), Turkey Dr. Karahan's research interests span multiple areas within cardiovascular medicine. He has made significant contributions to the field of mechanical circulatory support, particularly focusing on left ventricular assist devices (LVAD) and their applications in both adult and pediatric patients. His work explores minimally invasive approaches to LVAD implantation, management of complications, and integration with other cardiac procedures. Additionally, he has expertise in endovascular aortic repair techniques, including complex cases involving traumatic injuries and challenging anatomies. His research also extends to heart transplantation, anticoagulation management, and thrombophilia in vascular disease. Analysis of Dr. Karahan's recent publications reveals a strong focus on advancing mechanical circulatory support technologies, particularly LVAD systems. His work addresses critical challenges in the field including pediatric applications, minimally invasive techniques, management of complications like pump thrombosis, and integration with other cardiac procedures. He has also made significant contributions to endovascular aortic repair, developing innovative techniques for complex cases. His research demonstrates a multidisciplinary approach that bridges surgical innovation with patient-centered outcomes. Dr. Karahan is an active member of several professional organizations: European Association for Cardio-Thoracic Surgery (EACTS) - Member since 2024 International Society for Heart and Lung Transplantation (ISHLT) - Member since 2023 National Association of Vascular and Endovascular Surgery - Member since 2020 Turkish Cardiovascular Surgery Association - Member since 2014 He has served as an editor for The Turkish Journal of Thoracic and Cardiovascular Surgery (2025). His clinical work involves complex cardiovascular procedures, with a particular emphasis on innovative approaches to mechanical circulatory support and endovascular interventions. Dr. Karahan has presented his research at numerous national and international conferences, contributing to the advancement of cardiovascular surgical techniques. His professional experience includes positions at Gaziantep University, Ankara Bilkent City Hospital, and Turkey High Specialization Hospital. He has also gained international experience through observer positions at Paracelsus Medical University-Nuremberg Clinic, Hannover Medical School, University of Geneva, and Harvard University.

• Medical Imaging
• Nuclear Medicine
• Radiation Dosimetry
• +۳ مورد دیگر

Hunor Kertész is a Research Fellow at the University of Sydney's Image X Institute, affiliated with the Discipline of Medical Imaging Sciences in the School of Health Sciences. His research focuses on advancing medical imaging technologies, particularly in PET (Positron Emission Tomography) and CT (Computed Tomography) systems, with an emphasis on improving image quality, reducing radiation exposure, and developing novel imaging tools. His work spans several key areas: optimizing positron range correction in PET/CT for cardiac and oncology applications, exploring low-dose imaging techniques for pediatric patients, and creating open-source software tools like Dvgardener for medical image processing. He has contributed to the development of anthropomorphic phantoms for clinical simulations and portable CT systems for lung cancer screening. Recent publications highlight advancements in PET/MRI dose reduction for epilepsy patients, high-resolution total-body PET/CT through positron range correction, and the validation of Rubidium-82 myocardial imaging methods. His research often intersects with radiation dosimetry, image reconstruction algorithms, and 3D-printed anatomical models for quality assurance. While not explicitly mentioned, his contributions likely involve collaborations with clinical teams to translate imaging innovations into practical diagnostic solutions.

• Radiation Biophysics
• Cancer Radiotherapy
• Ionizing Radiation Effects
• +۴ مورد دیگر

David J. Brenner serves as Higgins Professor of Radiation Biophysics in Radiation Oncology and Environmental Health Sciences at Columbia University Medical Center. He directs both the century-old Center for Radiological Research and the Radiological Research Accelerator Facility (RARAF), leading interdisciplinary teams focused on radiation applications in medicine and safety. BA in Physics from Oxford University (1974) MSc in Radiation Physics from University of London (1976) MA in Physics Philosophy from Oxford University (1979) PhD in Physics from University of Surrey (1980) His research spans dual aspects of radiation: therapeutic applications in cancer treatment and risk assessment across diverse scenarios. Key initiatives include advancing carbon-ion therapy for pancreatic cancer, developing safe far-UVC light for pathogen elimination, and investigating low-dose radiation risks from medical imaging to nuclear terrorism. His team leverages RARAF's unique capabilities for mechanistic studies of radiation effects. Publications reveal dominant themes in radiation biophysics, with significant contributions to biodosimetry (RABiT platform), UV disinfection technology, and cancer risk modeling. Recent work emphasizes translational applications including medical countermeasures for radiation exposure and precision radiation oncology techniques. National Academy of Sciences Nuclear and Radiation Studies Board member National Council on Radiation Protection and Measurements member Radiation Research Society Failla Gold Medal recipient (2011) Oxford University Weldon Prize for mathematical biology (2015) Robert D. Moseley Award for Radiation Protection in Medicine Brenner leads multiple NIH-funded projects including biodosimetry development and UV disinfection research. His mentorship extends through directing Columbia's Radiological Research Accelerator Facility and training programs in radiological sciences. Current lab efforts focus on carbon-ion therapy mechanisms and 222-nm UV applications against drug-resistant pathogens, with active collaborations across oncology, microbiology, and physics disciplines.

Leah Schubertمشاهده پروفایل

دانشیار

• Medical Physics Education
• Radiation Oncology Safety
• Quality Assurance
• +۶ مورد دیگر

Leah Schubert, PhD is an Associate Professor in the Department of Radiation Oncology at the University of Colorado Anschutz Medical Campus School of Medicine. She serves as Director of the Medical Physics Residency Program, leading educational initiatives in medical physics training. Her professional focus centers on improving safety, quality, and educational standards in radiation oncology physics. Dr. Schubert earned her PhD from the University of Wisconsin - Madison in 2009 and completed her undergraduate studies with a BS from the University of California–San Diego in 2003. She is board certified in Therapeutic Medical Physics by the American Board of Radiology (2012). Her research spans medical physics education, radiation safety, quality assurance, and functional imaging applications in radiation therapy. She has pioneered work in physics plan review training, safety checklist implementation, and 4DCT-ventilation imaging for functional avoidance radiation therapy. Her educational research focuses on concept inventories, virtual interviewing for residency matches, and cross-institutional residency training frameworks. Analysis of her recent publications reveals a consistent focus on improving safety culture in radiation oncology through systematic approaches including failure modes and effects analysis, simulated error training, and safety checklist development. Her work increasingly incorporates cross-institutional collaboration and educational innovation in medical physics training. ABR Volunteer Services Award, American Board of Radiology (2023) Board Member at Large, Society of Directors of Academic Medical Physics Programs (2022) AAPM Fellow, American Association of Physicists in Medicine (2022) Excellent Patient Safety Role Model, University of Colorado Hospital (2021) ABR Volunteer Services Award, American Board of Radiology (2020) IAEA Competition Towards a Strong Safety Culture in Radiation Medicine, International Atomic Energy Agency (2019) As Director of the Medical Physics Residency Program, Dr. Schubert oversees comprehensive training for future medical physicists, implementing innovative approaches to curriculum development and assessment. Her leadership extends to national committees including the AAPM Work Group on Periodic Review of Medical Physics Residency Training and various SDAMPP committees. She has secured funding for educational initiatives focused on improving residency training standards and safety culture development. Dr. Schubert collaborates extensively with multi-institutional research teams, particularly in the area of 4DCT-ventilation imaging and its clinical applications for functional avoidance radiation therapy. Her work bridges clinical practice, safety initiatives, and educational innovation in medical physics.

• Knee Osteoarthritis
• Biomechanics
• Rehabilitation Science
• +۷ مورد دیگر

Monica Maly is a Part-Time Associate Professor in Rehabilitation Science within the Faculty of Health Sciences at McMaster University. Her academic profile demonstrates extensive expertise in biomechanics and rehabilitation, with particular focus on knee osteoarthritis research. She maintains an active research program with numerous recent publications spanning rheumatology, biomechanics, and rehabilitation science. Dr. Maly's research interests center on understanding the biomechanical and physiological factors contributing to knee osteoarthritis progression and developing effective interventions. Her work examines knee joint mechanics, muscle strength and capacity, gait analysis, pain management strategies, and the impact of exercise interventions on OA symptoms. She has conducted significant research on sex differences in OA, racial disparities in pain experiences, and the relationship between obesity, inflammation, and joint function. Her methodological approaches include biomechanical analysis, clinical trials, systematic reviews, and innovative technologies like soft robotics for knee bracing. Analysis of her recent publications (2023-2025) reveals a strong focus on understanding knee osteoarthritis mechanisms through biomechanical and physiological lenses, with increasing attention to social determinants of health and health disparities. Her work spans multiple disciplines including rheumatology, biomechanics, rehabilitation science, and public health, demonstrating interdisciplinary collaboration. Key trends include examining racial disparities in pain experiences, developing novel interventions like soft robotic knee braces, and investigating the complex relationships between joint loading, biomarkers, and cartilage changes. Dr. Maly has collaborated extensively with researchers across multiple institutions, as evidenced by her numerous publications in high-impact journals such as Osteoarthritis and Cartilage, Arthritis & Rheumatology, and Clinical Biomechanics. Her work often utilizes data from large longitudinal studies including the Osteoarthritis Initiative and the Canadian Longitudinal Study on Aging. While specific grant information isn't detailed in the provided text, her extensive publication record suggests successful funding of multiple research projects.

Mattias Brunströmمشاهده پروفایل

استادیار

• Cardiovascular Disease
• Hypertension
• Aortic Diseases
• +۳ مورد دیگر

Mattias Brunström serves as Assistant Professor of Cardiology and Associate Professor of Epidemiology at Umeå University's Faculty of Medicine within the Department of Public Health and Clinical Medicine, Section of Cardiology. He is concurrently a resident physician at Norrlands University Hospital and holds leadership roles as chairman of Sweden's national hypertension working group and scientific secretary of the Swedish Society for Hypertension, Stroke and Vascular Medicine, with active participation in the European and International Societies of Hypertension. His academic foundation includes a 2018 PhD thesis examining blood pressure-lowering treatment effects across different blood pressure levels through systematic reviews and meta-analyses of randomized clinical trials. This doctoral work established his expertise in evidence-based cardiovascular therapeutics and epidemiological methodology. Dr. Brunström's research program centers on cardiovascular disease risk factors, with specialized focus on hypertension pathophysiology and aortic diseases. His group investigates how adolescent blood pressure levels predict future cardiovascular events, examining interactions with obesity, physical fitness, and diabetes to improve risk stratification. They also analyze differential effects of antihypertensive drug classes on cardiovascular outcomes and study risk factors for aortic dissection/rupture to optimize preventive surgical interventions. This work addresses critical gaps in managing the world's leading cause of death, where uncontrolled hypertension contributes to 10 million annual fatalities despite effective treatments. Analysis of his 2024-2025 publications reveals dominant themes in hypertension guideline development, treatment threshold controversies, and cardiovascular risk assessment. His work frequently challenges conventional approaches (e.g., questioning excessive treatment of 'elevated' blood pressure in elderly patients) while advancing evidence for lifestyle interventions and beta-blocker utility. Methodologically, his research leverages large cohort studies (including 1.4 million enlistee data), systematic reviews, and international collaborations through societies like ESH and ISH to translate epidemiological findings into clinical practice. Dr. Brunström leads multiple funded research initiatives including 'Remission of type 2 diabetes through eHealth' (2022-2028) and 'VIPviza' (2013-2027), directing a multidisciplinary team that bridges clinical cardiology, epidemiology, and public health. His advisory role extends to national guideline committees and international hypertension societies where he shapes clinical practice through evidence synthesis and position papers. Based at Norrlands University Hospital's Cardiology Section, his research group operates within Umeå University's strong cardiovascular research ecosystem, maintaining active collaborations with the Swedish National Diabetes Register and international consortia. Their work emphasizes real-world applicability, examining topics like bedtime dosing of antihypertensives and self-report diagnostic tools to overcome barriers in hypertension control where only 25% of affected individuals achieve target blood pressure levels.

Allon Guezمشاهده پروفایل

استاد

• Control Systems
• Robotics
• Artificial Intelligence
• +۷ مورد دیگر

Allon Guez is a Professor in the Department of Electrical and Computer Engineering at Drexel University. His research focuses on control systems, robotics, artificial intelligence, medical robotics, and automated decision making. He actively bridges academia and industry through high-tech entrepreneurship. Education PhD in Electrical Engineering, University of Florida MS in Electrical Engineering, University of Florida MBA in Finance, Drexel University BS in Electrical Engineering, Technion - Israel Institute of Technology His research portfolio spans medical robotics, automated decision making systems, and advanced control algorithms. Key areas include wearable safety devices, radiation control in imaging systems, and closed-loop brain stimulation technologies. Notable contributions include founding ControlRad (radiation reduction systems) and GraceFall (fall detection technology). His work demonstrates a strong emphasis on translating academic research into commercial medical devices. Recent publications highlight innovations in: Fetal brainwave monitoring Postural disturbance detection Seizure prediction algorithms Magnetic microrobotics Dynamic CT collimation Cardiac tissue modeling